<DOC>
	<DOCNO>NCT00482170</DOCNO>
	<brief_summary>Primary objective study compare patient satisfaction prefilled syringe ( PFS ) auto-injector ( AI ) , two different delivery device etanercept 12 week use , use 10 point scale form totally dissatisfied totally satisfied.Secondary evaluation focus identification patient device attribute associate patient satisfaction .</brief_summary>
	<brief_title>Compare Perceptions Satisfaction Two Different Delivery Mechanisms Etanercept</brief_title>
	<detailed_description>For measure patient 's satisfaction perception , device , standard Likert scale use . This allow magnitude individual 's perception satisfaction measure multipoint scale anchor end . In addition , study describe patient perception related device attribute , importance describe overall patient perception . A range potential device benefit ( e.g . ease use , convenience , injection site pain , injection anxiety , injection confidence ) capture use questionnaire . The study aim characterize patient attribute indicate one device may result great patient satisfaction another . Patient attribute compose patient characteristic ( e.g . age , sex , demographic , social educational status psychological status , willingness self-manage , injection experience ) Psoriasis characteristic ( e.g . disease severity , disease duration , co morbidity , prior treatment , quality life ) . The study also take opportunity measure health outcome measure may important difference cost train patient support two device .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Treatment adult moderate severe plaque psoriasis fail respond , contraindication , intolerant systemic therapy include cyclosporine , methotrexate PUVA Eligible treatment etanercept accord Summary Product Characteristics ( SmPC ) , applicable local guideline . Aged 18 year Willing able selfinject etanercept . Able store test drug 28oC . Negative serum ßhuman chorionic gonadotropin ( ßHCG ) pregnancy test baseline ( week 0 ) woman childbearing potential . Sexually active woman childbearing potential must use medically acceptable form contraception . Medically acceptable form contraception include oral contraceptive , injectable implantable method , intrauterine device , properly use barrier contraception . Sexually active men must agree use reliable form contraception study . Capable understanding willing provide sign dated write voluntary informed consent protocolspecific procedure perform . Prior experience biologics antiTNF treatment Psoriasis include etanercept . Sepsis risk sepsis . Current recent infection , include chronic localize . Latex sensitivity . Vaccination live vaccine last 4 week , expect require vaccination course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>